Advancing together and moving forward: Combination gene and cellular immunotherapies

• Saul J. Priceman,
• Waseem Cheema,
• Prasad S. Adusumilli

Affiliations

Saul J. Priceman

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA; Department of Immuno-Oncology, Beckman Research Institute of City of Hope, Duarte, CA, USA; Corresponding author Saul J. Priceman, PhD, Assistant Professor, Departments of Hematology & Hematopoietic Cell Transplantation and Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010.

Waseem Cheema

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Prasad S. Adusumilli

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Corresponding author Prasad S. Adusumilli, MD, FACS, Attending and Deputy Chief, Thoracic Surgery; Vice Chair, Department of Surgery; Director, Mesothelioma Program; Head, Solid Tumors Cell Therapy, Cellular Therapeutics Center; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065.